In a report released yesterday, Joanna Gajuk from Bank of America Securities reiterated a Sell rating on Aveanna Healthcare Holdings (AVAH – Research Report), with a price target of $0.95. The company’s shares closed yesterday at $1.09.
According to TipRanks, Gajuk is a 3-star analyst with an average return of 7.6% and a 62.16% success rate. Gajuk covers the Healthcare sector, focusing on stocks such as Option Care Health, Addus Homecare, and Chemed.
The word on The Street in general, suggests a Hold analyst consensus rating for Aveanna Healthcare Holdings with a $1.51 average price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $3.15 and a one-year low of $0.67. Currently, Aveanna Healthcare Holdings has an average volume of 472.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aveanna Healthcare Holdings Inc is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. It directly address the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.
Read More on AVAH:
- Aveanna Healthcare Holdings Announces First Quarter 2023 Financial Results
- Aveanna Announces First Quarter 2023 Earnings Release Date and Conference Call
- Aveanna price target lowered to $3 from $4 at Raymond James
- Aveanna price target lowered to $1.70 from $3 at Deutsche Bank
- Aveanna sees FY23 revenue at least $1.84B, consensus $1.84B
